AFAP1-AS1 |
Upregulated |
Invasion and metastasis |
Promoting |
(25) |
AC006050.3-003 |
Upregulated |
Drug-resistance |
Promoting |
(26) |
AK126698 |
Downregulated |
Drug-resistance |
Inhibiting |
(27) |
BANCR |
Downregulated |
Invasion and metastasis |
Inhibiting |
(28,29) |
ANRIL |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(30,31) |
BCYRN1 |
Upregulated |
Invasion and metastasis |
Promoting |
(32) |
CAR10 |
Upregulated |
Proliferation and apoptosis |
Promoting |
(33) |
CCAT1 |
Upregulated |
Cancer initiation, proliferation and apoptosis, drug-resistance |
Promoting |
(34,35) |
CCAT2 |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(36-38) |
DLX6-AS1 |
Upregulated |
Unexplored |
Promoting |
(39) |
DQ786227 |
Upregulated |
Cancer initiation |
Promoting |
(40) |
GAS5 |
Downregulated |
Proliferation and apoptosis, drug-resistance |
Inhibiting |
(41-45) |
GAS6-as1 |
Downregulated |
Unexplored |
Inhibiting |
(46) |
GHSROS |
Upregulated |
Invasion and metastasis |
Promoting |
(47) |
H19 |
Upregulated |
Cancer initiation, proliferation and apoptosis |
Promoting |
(48-54) |
HMlincRNA717 |
Downregulated |
Unexplored |
Inhibiting |
(55) |
HNF1A-AS1 |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(56) |
HOTAIR |
Upregulated |
Cancer initiation, drug-resistance, proliferation and apoptosis, invasion and metastasis |
Promoting |
(57-64) |
LINC01133 |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(65-67) |
LINCRNA-p21 |
Downregulated |
Proliferation and apoptosis |
Inhibiting |
(13,68) |
lnc-bc060912 |
Upregulated |
Proliferation and apoptosis |
Promoting |
(69) |
loc728228 |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(70) |
LUADT1 |
Upregulated |
Proliferation and apoptosis |
Promoting |
(71) |
MALAT1 |
Upregulated |
Invasion and metastasis |
Promoting |
(72-80) |
MEG3 |
Downregulated |
Cancer initiation, proliferation and apoptosis, drug-resistance |
Inhibiting |
(81-83) |
LINC00115 |
Upregulated |
Unexplored |
Unexplored |
(84) |
MIAT1 |
Upregulated |
Unexplored |
Unexplored |
(84) |
MVIH |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(85) |
NEAT1 |
Upregulated |
Proliferation and apoptosis, drug-resistance |
Promoting |
(86,87) |
NKX2-1-AS1 |
Upregulated |
Proliferation and apoptosis |
Promoting |
(88) |
PANDAR |
Downregulated |
Proliferation and apoptosis |
Inhibiting |
(89) |
DRAIC |
Downregulated |
Invasion and metastasis |
Inhibiting |
(90) |
PVT1 |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(91,92) |
RGMB-AS1 |
Upregulated |
Proliferation and apoptosis, invasion and metastasis |
Promoting |
(93) |
SCAL1 |
Upregulated |
Proliferation and apoptosis, anti-cytotoxic effect |
Promoting |
(94,95) |
SOX2-OT |
Upregulated |
Proliferation and apoptosis |
Promoting |
(96) |
SPRY4-IT1 |
Upregulated |
Invasion and metastasis |
Promoting |
(97) |
TUG1 |
Downregulated |
Proliferation and apoptosis |
Inhibiting |
(98) |
ZXF1 |
Upregulated |
Invasion and metastasis |
Promoting |
(99) |
lncRNA-LET |
Downregulated |
Invasion and metastasis |
Inhibiting |
(100) |
UCA1 |
Upregulated |
Drug-resistance |
Promoting |
(101) |
XIST |
Upregulated |
Invasion and metastasis |
Promoting |
(102) |